JP2021523695A5 - - Google Patents

Info

Publication number
JP2021523695A5
JP2021523695A5 JP2020558967A JP2020558967A JP2021523695A5 JP 2021523695 A5 JP2021523695 A5 JP 2021523695A5 JP 2020558967 A JP2020558967 A JP 2020558967A JP 2020558967 A JP2020558967 A JP 2020558967A JP 2021523695 A5 JP2021523695 A5 JP 2021523695A5
Authority
JP
Japan
Prior art keywords
human
mononegavirus
vector
vector according
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020558967A
Other languages
English (en)
Japanese (ja)
Other versions
JP7371009B2 (ja
JP2021523695A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/028771 external-priority patent/WO2019209859A1/en
Publication of JP2021523695A publication Critical patent/JP2021523695A/ja
Publication of JP2021523695A5 publication Critical patent/JP2021523695A5/ja
Priority to JP2023179912A priority Critical patent/JP2024020214A/ja
Application granted granted Critical
Publication of JP7371009B2 publication Critical patent/JP7371009B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020558967A 2018-04-23 2019-04-23 キメラベクター Active JP7371009B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023179912A JP2024020214A (ja) 2018-04-23 2023-10-18 キメラベクター

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862661320P 2018-04-23 2018-04-23
US62/661,320 2018-04-23
PCT/US2019/028771 WO2019209859A1 (en) 2018-04-23 2019-04-23 Chimeric vectors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023179912A Division JP2024020214A (ja) 2018-04-23 2023-10-18 キメラベクター

Publications (3)

Publication Number Publication Date
JP2021523695A JP2021523695A (ja) 2021-09-09
JP2021523695A5 true JP2021523695A5 (https=) 2022-05-06
JP7371009B2 JP7371009B2 (ja) 2023-10-30

Family

ID=66794071

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020558967A Active JP7371009B2 (ja) 2018-04-23 2019-04-23 キメラベクター
JP2023179912A Pending JP2024020214A (ja) 2018-04-23 2023-10-18 キメラベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023179912A Pending JP2024020214A (ja) 2018-04-23 2023-10-18 キメラベクター

Country Status (10)

Country Link
US (2) US12071632B2 (https=)
EP (1) EP3784788A1 (https=)
JP (2) JP7371009B2 (https=)
KR (1) KR20210005090A (https=)
CN (1) CN112262215B (https=)
AU (1) AU2019261570B2 (https=)
BR (1) BR112020021652A2 (https=)
CA (1) CA3097888A1 (https=)
TW (2) TW202440937A (https=)
WO (1) WO2019209859A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190256A1 (ar) 2017-05-12 2019-10-28 Icahn School Med Mount Sinai فيروسات داء نيوكاسل واستخداماتها
WO2020037215A1 (en) 2018-08-17 2020-02-20 Icahn School Of Medicine At Mount Sinai Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease
CN114685627A (zh) * 2020-12-28 2022-07-01 广州更新生物医药科技有限公司 一种预防呼吸道合胞病毒的rAAV载体疫苗
WO2024238911A1 (en) * 2023-05-17 2024-11-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant murine pneumonia virus expressing severe acute respiratory syndrome coronavirus 2 (sars-cov-2) spike protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE419369T1 (de) 1999-07-09 2009-01-15 Us Gov Health & Human Serv Chimäre mensch-rinder respiratory syncytial virus vakzinen
KR20040002853A (ko) 2001-01-19 2004-01-07 비로노바티브 비.브이. 감응성 포유류에서 호흡계 질환을 유발하는 바이러스
US8715922B2 (en) 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
TW200636064A (en) 2004-10-28 2006-10-16 Centocor Inc Anti-respiratory syncytial virus antibodies, antigens and uses thereof
LT2285408T (lt) * 2008-06-05 2019-01-25 Ablynx N.V. Aminorūgščių sekos, nukreiptos prieš viruso apvalkalo baltymus, ir tokias sekas turintys polipeptidai, skirti virusinių ligų gydymui
DK3247388T3 (da) 2015-01-20 2025-12-22 Us Health Rekombinant human/bovin parainfluenzavirus 3 (b/hpiv3), der udtrykker et kimærisk rsv/bpiv3 f-protein, og anvendelser deraf

Similar Documents

Publication Publication Date Title
JP2021523695A5 (https=)
Carvalho et al. Bacteriophages and their derivatives for the treatment and control of food-producing animal infections
JP2018520997A5 (https=)
JP2019506175A5 (https=)
JP2017048194A5 (https=)
JP2014042533A5 (https=)
EP3424524A3 (en) Cancer rna-vaccine
Li et al. Isolation and characterization of a new class of DNA aptamers specific binding to Singapore grouper iridovirus (SGIV) with antiviral activities
JP2018523668A5 (https=)
CN103467571B (zh) 一种畜禽免疫增强剂法氏囊多肽
JP2023513592A5 (https=)
JP2006514549A5 (https=)
Xu et al. Differential modulation of avian β-defensin and Toll-like receptor expression in chickens infected with infectious bronchitis virus
Wang et al. Immune responses of chickens inoculated with recombinant Lactobacillus expressing the haemagglutinin of the avian influenza virus
RU2018137855A (ru) Холодоадаптированная живая аттенуированная вакцина с удаленным фактором вирулентности, подходящая для доставки через слизистые оболочки
Kang et al. Characterization of nasal cavity‐associated lymphoid tissue in ducks
JP2006512078A5 (https=)
Kim et al. Cross-protective immune responses elicited by a Korean variant of infectious bronchitis virus
Lemon et al. A review of UK-registered and candidate vaccines for bovine respiratory disease
Milani et al. Vaccine immune pressure influences viral population complexity of avian influenza virus during infection
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
KR101329348B1 (ko) 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스
CN102603898B (zh) 与i群禽腺病毒免疫相关融合蛋白及其编码基因与应用
Rahman et al. Modulation of humoral and cell-mediated immunity against avian influenza and Newcastle disease vaccines by oral administration of Salmonella enterica serovar typhimurium expressing chicken interleukin-18
Zheng et al. Assessment of recombinant Lactobacillus vector-based expressing IFITM3 protein anti-PRV infection in mice.